000			02153 a2200601 4500
005			20250514064835.0
264		0	_c20030618
008			200306s 0 0 eng d
022			_a0022-3042
024	7		_a10.1046/j.1471-4159.2003.01759.x _2doi
040			_aNLM _beng _cNLM
100	1		_aMaccarrone, Mauro
245	0	0	_aLevodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. _h[electronic resource]
260			_bJournal of neurochemistry _cMay 2003
300			_a1018-25 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmidohydrolases _xmetabolism
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xtherapeutic use
650	0	4	_aArachidonic Acids _xmetabolism
650	0	4	_aBinding, Competitive _xdrug effects
650	0	4	_aCannabinoid Receptor Modulators
650	0	4	_aCerebellum _xdrug effects
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aCyclohexanols _xpharmacokinetics
650	0	4	_aDisease Models, Animal
650	0	4	_aEndocannabinoids
650	0	4	_aExcitatory Postsynaptic Potentials _xdrug effects
650	0	4	_aFatty Acids, Unsaturated _xmetabolism
650	0	4	_aGlutamic Acid _xmetabolism
650	0	4	_aGlycerides _xmetabolism
650	0	4	_aIn Vitro Techniques
650	0	4	_aLevodopa _xtherapeutic use
650	0	4	_aOxidopamine
650	0	4	_aParkinsonian Disorders _xchemically induced
650	0	4	_aPatch-Clamp Techniques
650	0	4	_aPhospholipase D _xmetabolism
650	0	4	_aPolyunsaturated Alkamides
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Cannabinoid
650	0	4	_aReceptors, Drug _xagonists
700	1		_aGubellini, Paolo
700	1		_aBari, Monica
700	1		_aPicconi, Barbara
700	1		_aBattista, Natalia
700	1		_aCentonze, Diego
700	1		_aBernardi, Giorgio
700	1		_aFinazzi-Agrò, Alessandro
700	1		_aCalabresi, Paolo
773	0		_tJournal of neurochemistry _gvol. 85 _gno. 4 _gp. 1018-25
856	4	0	_uhttps://doi.org/10.1046/j.1471-4159.2003.01759.x _zAvailable from publisher's website
999			_c12507346 _d12507346